Oral CBD Delayed and Prolonged THC Effects in a Historical Human Experiment

A historical human experiment summarized in the CBD–THC review described delayed onset and prolonged THC effects when oral CBD was added. A delayed response was not the same as an eliminated response.

The preparation and route were defined

The review’s table describes Hollister and Gillespie’s study of 30 healthy volunteers using 20 mg THC and 40 mg CBD, both orally. Its summary says CBD delayed the onset and prolonged the effects of THC. The finding concerns that administered combination and route, rather than smoked cannabis or every CBD-to-THC ratio.

One observation time can conceal a shifted response

If an effect begins later, an early assessment may miss a response that appears subsequently. If the effect also lasts longer, a later observation may differ from what an early impression suggested. These are implications of the reported time-course pattern, not new estimates of onset or recovery. The supplied review does not justify assigning an exact duration to an individual.

Timing is distinct from pharmacological neutralization

The table does not establish that CBD removed THC exposure, reversed impairment or made the combination safe for complex activity. Nor does its summary identify a proven mechanism for the delayed and prolonged response. A careful citation retains the oral doses and the historical source while describing the temporal effect accurately. Calling every CBD interaction protective would miss the possibility that the interaction changes when effects are experienced rather than simply reducing them.

Related analysis: the broader evidence and its limitations.

Research cited

This analysis uses the supplied review; individual experiments are discussed as summarized there: Niesink and van Laar (2013). Does cannabidiol protect against adverse psychological effects of THC?

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

Adding CBD in a Small MS Cannabis-Extract Trial Was Associated With More Adverse Events

A small MS trial summarized in the early human CBD review reported more adverse events with a CBD-containing cannabis extract than with THC alone. The combination did not demonstrate a general safety advantage. The study had a defined clinical comparison The review describes a four-week crossover study involving 16 patients…

Spread the love

Read Article: Adding CBD in a Small MS Cannabis-Extract Trial Was Associated With More Adverse Events

A Cancer-Anorexia Cannabis Trial Stopped at Interim Analysis for Lack of Group Differences

A cancer-related anorexia trial summarized in the early human CBD review was terminated at interim analysis because the study arms did not differ. Its combination treatment did not supply positive appetite-treatment evidence in that comparison. The trial compared more than one active preparation The review describes 243 patients assigned to…

Spread the love

Read Article: A Cancer-Anorexia Cannabis Trial Stopped at Interim Analysis for Lack of Group Differences

A CBD–Nabilone Experiment Reported Only Marginal Changes in Intoxication and Depth Perception

A small historical crossover experiment summarized in the human CBD review reported marginal reductions in nabilone-related intoxication and binocular depth-perception impairment. It did not establish broad protection against synthetic-cannabinoid effects. The comparison involved a specific synthetic cannabinoid Nine male participants received oral CBD at 200 mg, alone and with nabilone…

Spread the love

Read Article: A CBD–Nabilone Experiment Reported Only Marginal Changes in Intoxication and Depth Perception

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us